" class="no-js "lang="en-US"> Mergers & Aquisitions Archives - Page 2 of 12 - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Pheno Therapeutics Announces Worldwide License from UCB to a Novel Program for Neurodegenerative Disease

Pheno Therapeutics, a biotechnology company focused on the discovery and development of small molecule therapeutics […]

JanOne Completes Acquisition of Soin Therapeutics

JanOne, a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced […]

Vistagen to Acquire Pherin Pharmaceuticals

Vistagen, a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living […]

KKR to Acquire Bushu Pharmaceuticals

KKR, a leading global investment firm, and Bushu Pharmaceuticals have announced the signing of definitive […]

SynAct Pharma to Make Strategic Acquisition of Swiss Biotech Company TXP Pharma

SynAct Pharma AB has announced that the company has entered into a conditional agreement on […]

Molecular Devices Acquires Cellesce, Expanding Industrywide Accessibility to Organoids

Molecular Devices, a leading provider of high-performance life science solutions, has announced the acquisition of […]

Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics

Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]

Essential Pharma Announces the Acquisition of HALDOL

Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access […]

Medical Mutual Finalizes Acquisition of Reserve National Insurance Company

On Dec. 1, 2022, Medical Mutual closed on the acquisition of Reserve National Insurance Company, […]

Inszone Insurance Services Completes Acquisition of Kirsch Insurance Group

Inszone Insurance Services, a rapidly growing, national provider of benefits, personal and commercial lines insurance, […]

  1. Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
  2. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  3. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  4. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  5. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more